Surface Modification Strategies for PTFE Artificial Vascular Grafts

PTFE artificial vascular grafts are widely recognized as the most reliable synthetic vascular substitute in modern vascular surgery, benefiting from their excellent mechanical stability, chemical inertness, and biocompatibility. Nevertheless, the ultra-inert and super-hydrophobic surface characteristics of pure PTFE severely restrict endothelial cell adhesion, proliferation, and tissue integration after implantation, resulting in insufficient long-term patency performance of small-diameter grafts. Surface modification has become the core technical means to break through the performance bottleneck of PTFE vascular grafts, which can effectively activate the inert PTFE surface, construct bionic biological interfaces, and realize functional upgrading of anti-thrombosis, anti-inflammation, and rapid endothelialization. A variety of mature and emerging surface modification strategies have been formed in the industry, covering physical modification, chemical modification, biological grafting, and composite coating technologies, providing systematic solutions for high-performance PTFE vascular prosthetics PTFE SHEET.

Physical surface modification is the most widely used and safe pretreatment strategy for PTFE vascular grafts, which improves surface activity without changing the intrinsic excellent mechanical properties of PTFE materials. Common physical modification technologies include plasma treatment, ultraviolet irradiation, laser micro-etching, and sandblasting roughening. Plasma modification is currently the most mainstream physical treatment method. Under high-energy plasma environment, inert fluorine atoms on the PTFE surface are stripped, and active hydroxyl and carboxyl functional groups are introduced, which significantly improves surface hydrophilicity and bonding activity. The treated PTFE surface changes from super-hydrophobic to moderately hydrophilic, which effectively reduces platelet adhesion and provides favorable conditions for subsequent biological coating and cell adhesion. Laser micro-etching technology can precisely construct bionic micro-nano rough structures on the surface of PTFE TUBE vascular grafts, simulating the micro-topography of natural vascular intima and further enhancing cell compatibility.

Chemical modification strategies focus on breaking the stable fluorocarbon molecular bonds of PTFE to realize permanent surface activation and functionalization. Traditional chemical etching adopts strong reducing reagent treatment to defluorinate the PTFE surface, forming a carbon-rich active layer with strong adhesion performance. Although chemical modification has excellent activation effect, the reaction process needs precise parameter control to avoid excessive corrosion affecting the mechanical strength of vascular grafts. Modern optimized chemical modification technologies adopt mild gradient reaction systems, which can uniformly activate the inner wall of PTFE vascular grafts while maintaining the structural integrity and mechanical toughness of the grafts. The chemically activated PTFE surface can stably bind various bioactive molecules, laying a foundation for long-term stable functional modification.

Biological grafting and functional coating modification are the core strategies to realize high hemocompatibility of PTFE vascular grafts. Based on physically and chemically activated PTFE surfaces, researchers immobilize a variety of bioactive substances including heparin, chitosan, collagen, gelatin, and vascular endothelial growth factor (VEGF). Heparin grafting modification can endow PTFE grafts with persistent anticoagulant function, significantly inhibiting acute thrombosis after implantation. Collagen and gelatin bionic coatings can simulate the extracellular matrix environment of natural blood vessels, promoting endothelial cell adhesion and proliferation and accelerating endothelialization. VEGF loaded coatings can intelligently recruit endothelial progenitor cells in blood, realizing rapid and complete endothelial layer coverage on the graft surface.

In recent years, intelligent responsive composite modification strategies have become an emerging research hotspot. This strategy constructs multi-layer functional composite structures on the PTFE surface, realizing synergistic effects of anticoagulation, anti-inflammation, antibacterial and rapid endothelialization. For example, the heparin-chitosan composite coating forms a polyelectrolyte multilayer structure, which not only has excellent anticoagulant performance but also inhibits bacterial adhesion and effectively prevents postoperative graft infection. The pH-responsive and temperature-responsive intelligent coatings can adjust the release rate of bioactive factors according to the in-vivo microenvironment changes, realizing precise and long-term functional regulation.

Different modification strategies have their own applicable scenarios and performance advantages. Physical modification is suitable for universal pretreatment of vascular grafts with high safety and stable quality; chemical modification is suitable for high-strength functional grafting requirements; biological composite modification is the best choice for high-end high-performance vascular grafts. Reasonable combination of multiple modification technologies can maximize the comprehensive performance of PTFE artificial vascular grafts, effectively solving the clinical pain points of thrombosis, stenosis, and infection. With the continuous innovation of surface modification technology, the biological performance of PTFE vascular grafts will be further close to autologous blood vessels, achieving breakthroughs in long-term patency rate of small-diameter vascular grafts.